Back To: Home

Our 2016 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
August 2016
The organizations are partnering to expand hematopoietic stem cell options...
by Mel J. Yeates
August 2016
International collaboration plans to create new cancer cell culture models to accelerate research...
by Jeffrey Bouley
August 2016
Gene-based and stem cell-based therapies look for synergies ...
by Randall C Willis
August 2016
Gur Roshwalb expands on the complement system and its treatment candidate for rare diseases triggered by complement dysregulation...
by Kelsey Kaustinen
Top Story
Guest Commentary:
The June 2016 issue had a second guest commentary (in addition to the one in the Editor's Focus section farther down this home page), not a common occurrence for us. And since the Editor's Focus area only allow three entries, we wanted to make sure it got some mention of its own. It's titled "Identification of durable, assessable biomarker signatures for parasite-induced cholangiocarcinoma" and you can read it by clicking here.

Editor's Focus:
August 2016
MilliporeSigma in June announced survey results of 250 global biopharmaceutical executives on how their companies will manage new risks associated with the changing biopharma landscape.. [ more ]
by Economist Intelligence Unit

August 2016
Children tend to get left out in the cold when it comes to clinical research, but they are an important population that deserves better consideration when it comes to developing therapeutics.. [ more ]
by Peter T. Kissinger

August 2016
True representation of the population in clinical trials is something we aren't yet achieving, but we need to get closer to that goal even if we never do truly reach it.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2016 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.